NEW YORK, March 26 - Affymetrix and Oxford Gene Technology said Monday they had settled a multinational patent infringement dispute, allowing both companies to proceed in licensing and developing their microarray technology.

The companies, which have been entrenched in a legal battle since 1999, would not disclose the terms of the settlement, but Affymetrix said that it would incure a $19 million charge as well as other possible legal fees.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.